Tempus AI
ISIN US88023B1035
|WKN A40EDP
Market cap (in EUR)
7,865.06 m
Country
United States
Sector
Healthcare
Dividend yield
0.00%
Overview
Description
Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.
Healthcare Healthcare Equipment Diagnostics and Drug Delivery Devices United States
Financials
Key metrics
| Market capitalisation, EUR | 7,865.06 m |
| EPS, EUR | -4.39 |
| P/B ratio | 148.69 |
| P/E ratio | - |
| Dividend yield | 0.00% |
Income statement (2024)
| Revenue, EUR | 641.03 m |
| Net income, EUR | -652.50 m |
| Profit margin | -101.79% |
What ETF is Tempus AI in?
There are 9 ETFs which contain Tempus AI. All of these ETFs are listed in the table below. The ETF with the largest weighting of Tempus AI is the ARK Genomic Revolution UCITS ETF USD Accumulating.
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.
Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.
Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.
